Chengxuan Tang

Dr. Chengxuan Tang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Biomaterials Research
Verified
Journal Article
Open access
PDF file
HCHan Chen
Han Chen
HXHuaqian Xue
Huaqian Xue
HZHuanxuan Zeng
Huanxuan Zeng
MDMinghai Dai
Minghai Dai
CTChengxuan Tang
Chengxuan Tang
LLLiangle Liu
Liangle Liu
Hyaluronic acid (HA) is widely distributed in human connective tissue, and its unique biological and physicochemical properties and ability to facilitate biological structure repair make it a promising candidate for three-dimensional (3D) bioprinting in the field of tissue regeneration and biomedical engineering. Moreover, HA is an ideal raw material for bioinks in tissue engineering because of its histocompatibility, non-immunogenicity, biodegradability, anti-inflammatory properties, anti-angiogenic properties, and modifiability. Tissue engineering is a multidisciplinary field focusing on in vitro reconstructions of mammalian tissues, such as cartilage tissue engineering, neural tissue engineering, skin tissue engineering, and other areas that require further clinical applications. In this review, we first describe the modification methods, cross-linking methods, and bioprinting strategies for HA and its derivatives as bioinks and then critically discuss the strengths, shortcomings, and feasibility of each method. Subsequently, we reviewed the practical clinical applications and outcomes of HA bioink in 3D bioprinting. Finally, we describe the challenges and opportunities in the development of HA bioink to provide further research references and insights.

13 November 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HXHuaqian Xue
Huaqian Xue
YJYikun Ju
Yikun Ju
XYXiuzhi Ye
Xiuzhi Ye
MDMinghai Dai
Minghai Dai
CTChengxuan Tang
Chengxuan Tang
LLLiangle Liu
Liangle Liu

18 February 2021 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
CWChenjian Wang
Chenjian Wang
TXTianzhen Xu
Tianzhen Xu
BLBrittany Bolduc Lachance
Brittany Bolduc Lachance
XZXiqiang Zhong
Xiqiang Zhong
GSGuangjie Shen
Guangjie Shen
Xiaofeng JiaXiaofeng Jia
Xiaofeng Jia
Background: The pathological process of traumatic spinal cord injury (SCI) involves excessive activation of microglia leading to the overproduction of proinflammatory cytokines and causing neuronal injury. Sphingosine kinase 1 (Sphk1), a key enzyme responsible for phosphorylating sphingosine into sphingosine-1-phosphate (S1P), plays an important role in mediating inflammation, cell proliferation, survival, and immunity.Methods: We aim to investigate the mechanism and pathway of the Sphk1-mediated neuroinflammatory response in a rodent model of SCI. Sixty Sprague-Dawley rats were randomly assigned to sham surgery, SCI, or PF543 (a specific Sphk1 inhibitor) groups. Functional outcomes included blinded hindlimb locomotor rating and inclined plane test.Results: We discovered that Sphk1 is upregulated in injured spinal cord tissue of rats after SCI and is associated with production of S1P and subsequent NF-κB p65 activation. PF543 attenuated p65 activation, reduced inflammatory response, and relieved neuronal damage, leading to improved functional recovery. Western blot analysis confirmed that expression of S1P receptor 3 (S1PR3) and phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) are activated in microglia of SCI rats and mitigated by PF543. In vitro, we demonstrated that Bay11-7085 suppressed NF-κB p65 and inhibited amplification of the inflammation cascade by S1P, reducing the release of proinflammatory TNF-α. We further confirmed that phosphorylation of p38 MAPK and activation of NF-κB p65 is inhibited by PF543 and CAY10444. p38 MAPK phosphorylation and NF-κB p65 activation were enhanced by exogenous S1P and inhibited by the specific inhibitor SB204580, ultimately indicating that the S1P/S1PR3/p38 MAPK pathway contributes to the NF-κB p65 inflammatory response.Conclusion: Our results demonstrate a critical role of Sphk1 in the post-traumatic SCI inflammatory cascade and present the Sphk1/S1P/S1PR3 axis as a potential target for therapeutic intervention to control neuroinflammation, relieve neuronal damage, and improve functional outcomes in SCI.

22 July 2024 in Heliyon
Verified
Journal Article
Open access
MLMeifen Liu
Meifen Liu
JJJiman Jin
Jiman Jin
XZXiqiang Zhong
Xiqiang Zhong
LLLiangle Liu
Liangle Liu
CTChengxuan Tang
Chengxuan Tang
LCLimei Cai
Limei Cai
Advances in the development and utilization of polysaccharide materials are highly promising, offering prominent applications in the field of tissue engineering for addressing diverse clinical needs, including wound healing, bone regeneration, cartilage repair, and treatment of conditions such as arthritis. Novel polysaccharide materials are popular owing to their inherent stability, biocompatibility, and repeatability. This review presents an overview of the biomedical applications of natural polysaccharide hydrogels and their derivatives. Herein, we discuss the latest advancements in the fabrication, physicochemical properties, and biomedical applications of polysaccharide-based hydrogels, including chitosan, hyaluronic acid, alginate, and cellulose. Various processing techniques applicable to polysaccharide materials are explored, such as the transformation of polysaccharide hydrogels into electrospun nanofibers, microneedles, microspheres, and nanogels. Furthermore, the use of polysaccharide hydrogels in the context of wound-healing applications, including hemostatic effects, antimicrobial activities, anti-inflammatory properties, and promotion of angiogenesis, is presented. Finally, we address the challenges encountered in the development of polysaccharide hydrogels and outline the potential prospects in this evolving field.

1 July 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
LLLing Liu
Ling Liu
FWFangyan Wang
Fangyan Wang
XCXiang Chen
Xiang Chen
LLLiangle Liu
Liangle Liu
YWYibing Wang
Yibing Wang
CTChengxuan Tang
Chengxuan Tang
This review focuses on the emerging technology of multifunctional microneedles (MNs) within the biomedical engineering (BME) field, highlighting their potential in drug delivery, diagnostics, and therapeutics. Previous studies have explored MNs in various applications; however, their diverse functionalities across different material types and advanced application domains have been rarely comprehensively explored. This review bridges this gap by providing insights into the application of MNs in materials science, drug delivery, diagnostic monitoring, and tissue engineering. The unique properties and skin effects of various inorganic (eg, silicon, metals) and organic materials (eg, polysaccharides, polymers, proteins) used in MNs are examined. The analysis emphasizes the advantages of different MN materials, ie, their biocompatibility, degradation rates, and application specificity. In addition, the preparation processes and application scenarios of each MN type, such as minimally invasive drug delivery in transdermal applications and their benefits in tissue engineering for promoting repair, regeneration, and precise delivery of cells and growth factors in tissues like skin, cartilage, muscle, bone, and nerves, are discussed. Furthermore, this review explores the innovative use of MNs in brain–computer interfaces—an area not yet thoroughly examined. This novel application offers significant opportunities in neuroscience and clinical practice. Overall, this review provides valuable insights into the current research landscape and unexplored areas of MNs, contributing to future advancements in BME.

7 September 2023 in Heliyon
Verified
Journal Article
Open access
ZJZhiqiang Jia
Zhiqiang Jia
HZHuanxuan Zeng
Huanxuan Zeng
XYXiuzhi Ye
Xiuzhi Ye
MDMinghai Dai
Minghai Dai
CTChengxuan Tang
Chengxuan Tang
LLLiangle Liu
Liangle Liu
Spinal cord injury (SCI) is characterized by damage resulting in dysfunction of the spinal cord. Hydrogels are common biomaterials that play an important role in the treatment of SCI. Hydrogels are biocompatible, and some have electrical conductivity that are compatible with spinal cord tissues. Hydrogels have a high drug-carrying capacity, allowing them to be used for SCI treatment through the loading of various types of active substances, drugs, or cells. We first discuss the basic anatomy and physiology of the human spinal cord and briefly discuss SCI and its treatment. Then, we describe different treatment strategies for SCI. We further discuss the crosslinking methods and classification of hydrogels and detail hydrogel biomaterials prepared using different processing methods for the treatment of SCI. Finally, we analyze the future applications and limitations of hydrogels for SCI. The development of biomaterials opens up new possibilities and options for the treatment of SCI. Thus, our findings will inspire scholars in related fields and promote the development of hydrogel therapy for SCI.